ADACEL-POLIO
Google image searchProduct monograph
Active ingredients
filamentous haemagglutinin, 5 MCG/0.5 ML
pertussis toxoid, 2.5 MCG/0.5 ML
pertactin, 3 MCG/0.5 ML
tetanus toxoid, 5 LF/0.5 ML
fimbriae types 2 and 3 (fim), 5 MCG/0.5 ML
poliovirus type 1 mahoney (inactivated), 29 UNIT/0.5 ML
poliovirus type 2 mef1 (inactivated), 7 UNIT/0.5 ML
poliovirus type 3 saukett (inactivated), 26 UNIT/0.5 ML
diphtheria toxoid, 2 LF/0.5 ML
DIN: 02352044
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 11-MAR-2011
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07C — BACTERIAL AND VIRAL VACCINES, COMBINED (ATC, ATC/DDD)
- J07CA — Bacterial and viral vaccines, combined (ATC, ATC/DDD)
- J07CA02 — DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS (ATC/DDD)
Reference brand drug: Adacel-polio, Boostrix-polio, Infanrix Hexa, Quadracel
External Links for Adacel-Polio
Search on Google
- Adacel-Polio side effects
- Adacel-Polio dosage
- filamentous haemagglutinin side effects
- filamentous haemagglutinin dosage
- pertussis toxoid side effects
- pertussis toxoid dosage
- pertactin side effects
- pertactin dosage
- tetanus toxoid side effects
- tetanus toxoid dosage
- fimbriae types 2 and 3 side effects
- fimbriae types 2 and 3 dosage
- poliovirus type 1 mahoney side effects
- poliovirus type 1 mahoney dosage
- poliovirus type 2 mef1 side effects
- poliovirus type 2 mef1 dosage
- poliovirus type 3 saukett side effects
- poliovirus type 3 saukett dosage
- diphtheria toxoid side effects
- diphtheria toxoid dosage
